LA JOLLA, Calif.--(BUSINESS WIRE)--CHI President and Chief Executive Officer David L. Gollaher, Ph.D., today provided testimony before the House Energy and Commerce Health Subcommittee on the regulatory environment for biomedical products and the impact on innovation and job creation.
